nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—TERT—liver cancer	0.486	0.898	CbGaD
Zidovudine—UGT2B7—Epirubicin—liver cancer	0.0849	0.295	CbGbCtD
Zidovudine—ABCC4—Sorafenib—liver cancer	0.0657	0.228	CbGbCtD
Zidovudine—ALB—liver cancer	0.0555	0.103	CbGaD
Zidovudine—ABCG2—Sorafenib—liver cancer	0.0354	0.123	CbGbCtD
Zidovudine—ABCG2—Doxorubicin—liver cancer	0.0215	0.0745	CbGbCtD
Zidovudine—CYP2C8—Sorafenib—liver cancer	0.0188	0.0654	CbGbCtD
Zidovudine—CYP2C19—Sorafenib—liver cancer	0.0158	0.0549	CbGbCtD
Zidovudine—CYP2C9—Sorafenib—liver cancer	0.0131	0.0456	CbGbCtD
Zidovudine—ABCB1—Sorafenib—liver cancer	0.0127	0.0443	CbGbCtD
Zidovudine—ABCB1—Doxorubicin—liver cancer	0.00773	0.0269	CbGbCtD
Zidovudine—CYP3A4—Sorafenib—liver cancer	0.00764	0.0265	CbGbCtD
Zidovudine—CYP3A4—Doxorubicin—liver cancer	0.00463	0.0161	CbGbCtD
Zidovudine—TERT—embryo—liver cancer	0.000716	0.251	CbGeAlD
Zidovudine—SLC28A1—liver—liver cancer	0.000338	0.118	CbGeAlD
Zidovudine—TERT—liver—liver cancer	0.000331	0.116	CbGeAlD
Zidovudine—Leukopenia—Sorafenib—liver cancer	0.000302	0.00388	CcSEcCtD
Zidovudine—Vasodilation procedure—Doxorubicin—liver cancer	0.0003	0.00386	CcSEcCtD
Zidovudine—Vasodilation—Doxorubicin—liver cancer	0.0003	0.00386	CcSEcCtD
Zidovudine—Loss of consciousness—Sorafenib—liver cancer	0.000297	0.00381	CcSEcCtD
Zidovudine—Cough—Sorafenib—liver cancer	0.000294	0.00378	CcSEcCtD
Zidovudine—Skin discolouration—Doxorubicin—liver cancer	0.000292	0.00375	CcSEcCtD
Zidovudine—Rectal haemorrhage—Doxorubicin—liver cancer	0.000292	0.00375	CcSEcCtD
Zidovudine—Hyperbilirubinaemia—Doxorubicin—liver cancer	0.00029	0.00373	CcSEcCtD
Zidovudine—Musculoskeletal pain—Epirubicin—liver cancer	0.000289	0.00371	CcSEcCtD
Zidovudine—Myalgia—Sorafenib—liver cancer	0.000287	0.00369	CcSEcCtD
Zidovudine—Arthralgia—Sorafenib—liver cancer	0.000287	0.00369	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000285	0.00367	CcSEcCtD
Zidovudine—Hepatocellular injury—Epirubicin—liver cancer	0.000285	0.00366	CcSEcCtD
Zidovudine—Eructation—Epirubicin—liver cancer	0.00028	0.0036	CcSEcCtD
Zidovudine—Cystitis noninfective—Epirubicin—liver cancer	0.000279	0.00358	CcSEcCtD
Zidovudine—Cystitis—Epirubicin—liver cancer	0.000275	0.00354	CcSEcCtD
Zidovudine—Anaphylactic shock—Sorafenib—liver cancer	0.000275	0.00354	CcSEcCtD
Zidovudine—Shock—Sorafenib—liver cancer	0.000271	0.00348	CcSEcCtD
Zidovudine—Fluid retention—Epirubicin—liver cancer	0.000271	0.00348	CcSEcCtD
Zidovudine—Nervous system disorder—Sorafenib—liver cancer	0.00027	0.00347	CcSEcCtD
Zidovudine—Thrombocytopenia—Sorafenib—liver cancer	0.00027	0.00346	CcSEcCtD
Zidovudine—Aplastic anaemia—Epirubicin—liver cancer	0.000268	0.00344	CcSEcCtD
Zidovudine—Neuropathy—Epirubicin—liver cancer	0.000268	0.00344	CcSEcCtD
Zidovudine—Skin disorder—Sorafenib—liver cancer	0.000268	0.00344	CcSEcCtD
Zidovudine—Musculoskeletal pain—Doxorubicin—liver cancer	0.000267	0.00343	CcSEcCtD
Zidovudine—Hepatocellular injury—Doxorubicin—liver cancer	0.000264	0.00339	CcSEcCtD
Zidovudine—Anorexia—Sorafenib—liver cancer	0.000263	0.00337	CcSEcCtD
Zidovudine—Eructation—Doxorubicin—liver cancer	0.000259	0.00333	CcSEcCtD
Zidovudine—Rash maculo-papular—Epirubicin—liver cancer	0.000259	0.00333	CcSEcCtD
Zidovudine—Mouth ulceration—Epirubicin—liver cancer	0.000258	0.00331	CcSEcCtD
Zidovudine—Bladder pain—Epirubicin—liver cancer	0.000258	0.00331	CcSEcCtD
Zidovudine—Cystitis noninfective—Doxorubicin—liver cancer	0.000258	0.00331	CcSEcCtD
Zidovudine—Cystitis—Doxorubicin—liver cancer	0.000255	0.00327	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000251	0.00322	CcSEcCtD
Zidovudine—Fluid retention—Doxorubicin—liver cancer	0.000251	0.00322	CcSEcCtD
Zidovudine—ALB—gall bladder—liver cancer	0.000249	0.0873	CbGeAlD
Zidovudine—Neuropathy—Doxorubicin—liver cancer	0.000248	0.00318	CcSEcCtD
Zidovudine—Aplastic anaemia—Doxorubicin—liver cancer	0.000248	0.00318	CcSEcCtD
Zidovudine—Dyspnoea—Sorafenib—liver cancer	0.000246	0.00315	CcSEcCtD
Zidovudine—Lymphadenopathy—Epirubicin—liver cancer	0.000243	0.00312	CcSEcCtD
Zidovudine—Dyspepsia—Sorafenib—liver cancer	0.000242	0.00311	CcSEcCtD
Zidovudine—Phlebitis—Epirubicin—liver cancer	0.00024	0.00309	CcSEcCtD
Zidovudine—Rash maculo-papular—Doxorubicin—liver cancer	0.00024	0.00308	CcSEcCtD
Zidovudine—Decreased appetite—Sorafenib—liver cancer	0.000239	0.00308	CcSEcCtD
Zidovudine—Mouth ulceration—Doxorubicin—liver cancer	0.000239	0.00307	CcSEcCtD
Zidovudine—Bladder pain—Doxorubicin—liver cancer	0.000239	0.00307	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Sorafenib—liver cancer	0.000238	0.00305	CcSEcCtD
Zidovudine—Fatigue—Sorafenib—liver cancer	0.000237	0.00305	CcSEcCtD
Zidovudine—Pain—Sorafenib—liver cancer	0.000236	0.00303	CcSEcCtD
Zidovudine—Constipation—Sorafenib—liver cancer	0.000236	0.00303	CcSEcCtD
Zidovudine—Cardiac failure congestive—Epirubicin—liver cancer	0.000228	0.00293	CcSEcCtD
Zidovudine—Gastrointestinal pain—Sorafenib—liver cancer	0.000225	0.00289	CcSEcCtD
Zidovudine—Lymphadenopathy—Doxorubicin—liver cancer	0.000225	0.00289	CcSEcCtD
Zidovudine—Phlebitis—Doxorubicin—liver cancer	0.000222	0.00286	CcSEcCtD
Zidovudine—Urticaria—Sorafenib—liver cancer	0.000219	0.00281	CcSEcCtD
Zidovudine—Body temperature increased—Sorafenib—liver cancer	0.000218	0.0028	CcSEcCtD
Zidovudine—Abdominal pain—Sorafenib—liver cancer	0.000218	0.0028	CcSEcCtD
Zidovudine—Cardiac failure congestive—Doxorubicin—liver cancer	0.000211	0.00271	CcSEcCtD
Zidovudine—Affect lability—Epirubicin—liver cancer	0.000204	0.00262	CcSEcCtD
Zidovudine—Asthenia—Sorafenib—liver cancer	0.000198	0.00254	CcSEcCtD
Zidovudine—Mood swings—Epirubicin—liver cancer	0.000196	0.00252	CcSEcCtD
Zidovudine—Pruritus—Sorafenib—liver cancer	0.000195	0.0025	CcSEcCtD
Zidovudine—Affect lability—Doxorubicin—liver cancer	0.000189	0.00242	CcSEcCtD
Zidovudine—SLC29A2—liver—liver cancer	0.000189	0.0662	CbGeAlD
Zidovudine—Diarrhoea—Sorafenib—liver cancer	0.000188	0.00242	CcSEcCtD
Zidovudine—Breast disorder—Epirubicin—liver cancer	0.000187	0.0024	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000186	0.0024	CcSEcCtD
Zidovudine—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000186	0.0024	CcSEcCtD
Zidovudine—Nasopharyngitis—Epirubicin—liver cancer	0.000185	0.00238	CcSEcCtD
Zidovudine—Dizziness—Sorafenib—liver cancer	0.000182	0.00234	CcSEcCtD
Zidovudine—Mood swings—Doxorubicin—liver cancer	0.000182	0.00233	CcSEcCtD
Zidovudine—Influenza—Epirubicin—liver cancer	0.000179	0.0023	CcSEcCtD
Zidovudine—Dysphagia—Epirubicin—liver cancer	0.000179	0.0023	CcSEcCtD
Zidovudine—Pancreatitis—Epirubicin—liver cancer	0.000175	0.00225	CcSEcCtD
Zidovudine—Vomiting—Sorafenib—liver cancer	0.000175	0.00225	CcSEcCtD
Zidovudine—Rash—Sorafenib—liver cancer	0.000174	0.00223	CcSEcCtD
Zidovudine—Dermatitis—Sorafenib—liver cancer	0.000174	0.00223	CcSEcCtD
Zidovudine—Breast disorder—Doxorubicin—liver cancer	0.000173	0.00222	CcSEcCtD
Zidovudine—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000173	0.00222	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000173	0.00222	CcSEcCtD
Zidovudine—Headache—Sorafenib—liver cancer	0.000173	0.00222	CcSEcCtD
Zidovudine—Nasopharyngitis—Doxorubicin—liver cancer	0.000171	0.0022	CcSEcCtD
Zidovudine—Pancytopenia—Epirubicin—liver cancer	0.00017	0.00218	CcSEcCtD
Zidovudine—Dysuria—Epirubicin—liver cancer	0.000167	0.00215	CcSEcCtD
Zidovudine—Neutropenia—Epirubicin—liver cancer	0.000167	0.00215	CcSEcCtD
Zidovudine—Dysphagia—Doxorubicin—liver cancer	0.000166	0.00213	CcSEcCtD
Zidovudine—Influenza—Doxorubicin—liver cancer	0.000166	0.00213	CcSEcCtD
Zidovudine—Pollakiuria—Epirubicin—liver cancer	0.000165	0.00212	CcSEcCtD
Zidovudine—Nausea—Sorafenib—liver cancer	0.000164	0.0021	CcSEcCtD
Zidovudine—Pancreatitis—Doxorubicin—liver cancer	0.000162	0.00209	CcSEcCtD
Zidovudine—Weight decreased—Epirubicin—liver cancer	0.000162	0.00208	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000158	0.00203	CcSEcCtD
Zidovudine—Pancytopenia—Doxorubicin—liver cancer	0.000157	0.00202	CcSEcCtD
Zidovudine—Neuropathy peripheral—Epirubicin—liver cancer	0.000156	0.00201	CcSEcCtD
Zidovudine—Stomatitis—Epirubicin—liver cancer	0.000156	0.002	CcSEcCtD
Zidovudine—Jaundice—Epirubicin—liver cancer	0.000156	0.002	CcSEcCtD
Zidovudine—Dysuria—Doxorubicin—liver cancer	0.000155	0.00199	CcSEcCtD
Zidovudine—Neutropenia—Doxorubicin—liver cancer	0.000155	0.00199	CcSEcCtD
Zidovudine—Sweating—Epirubicin—liver cancer	0.000153	0.00197	CcSEcCtD
Zidovudine—Pollakiuria—Doxorubicin—liver cancer	0.000153	0.00197	CcSEcCtD
Zidovudine—Haematuria—Epirubicin—liver cancer	0.000152	0.00195	CcSEcCtD
Zidovudine—Hepatobiliary disease—Epirubicin—liver cancer	0.000151	0.00194	CcSEcCtD
Zidovudine—Epistaxis—Epirubicin—liver cancer	0.000151	0.00193	CcSEcCtD
Zidovudine—Weight decreased—Doxorubicin—liver cancer	0.00015	0.00192	CcSEcCtD
Zidovudine—Sinusitis—Epirubicin—liver cancer	0.00015	0.00192	CcSEcCtD
Zidovudine—Agranulocytosis—Epirubicin—liver cancer	0.000149	0.00191	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000146	0.00188	CcSEcCtD
Zidovudine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000145	0.00186	CcSEcCtD
Zidovudine—Stomatitis—Doxorubicin—liver cancer	0.000144	0.00185	CcSEcCtD
Zidovudine—Jaundice—Doxorubicin—liver cancer	0.000144	0.00185	CcSEcCtD
Zidovudine—Rhinitis—Epirubicin—liver cancer	0.000144	0.00185	CcSEcCtD
Zidovudine—Hepatitis—Epirubicin—liver cancer	0.000143	0.00184	CcSEcCtD
Zidovudine—Pharyngitis—Epirubicin—liver cancer	0.000142	0.00183	CcSEcCtD
Zidovudine—Sweating—Doxorubicin—liver cancer	0.000142	0.00182	CcSEcCtD
Zidovudine—Urinary tract disorder—Epirubicin—liver cancer	0.000141	0.00182	CcSEcCtD
Zidovudine—Haematuria—Doxorubicin—liver cancer	0.000141	0.00181	CcSEcCtD
Zidovudine—Connective tissue disorder—Epirubicin—liver cancer	0.000141	0.00181	CcSEcCtD
Zidovudine—Urethral disorder—Epirubicin—liver cancer	0.00014	0.0018	CcSEcCtD
Zidovudine—Hepatobiliary disease—Doxorubicin—liver cancer	0.00014	0.00179	CcSEcCtD
Zidovudine—Epistaxis—Doxorubicin—liver cancer	0.000139	0.00179	CcSEcCtD
Zidovudine—Sinusitis—Doxorubicin—liver cancer	0.000139	0.00178	CcSEcCtD
Zidovudine—Agranulocytosis—Doxorubicin—liver cancer	0.000138	0.00177	CcSEcCtD
Zidovudine—Erythema multiforme—Epirubicin—liver cancer	0.000135	0.00174	CcSEcCtD
Zidovudine—Cardiac disorder—Epirubicin—liver cancer	0.000133	0.00171	CcSEcCtD
Zidovudine—Rhinitis—Doxorubicin—liver cancer	0.000133	0.00171	CcSEcCtD
Zidovudine—Hepatitis—Doxorubicin—liver cancer	0.000133	0.0017	CcSEcCtD
Zidovudine—Pharyngitis—Doxorubicin—liver cancer	0.000132	0.00169	CcSEcCtD
Zidovudine—Urinary tract disorder—Doxorubicin—liver cancer	0.000131	0.00168	CcSEcCtD
Zidovudine—Connective tissue disorder—Doxorubicin—liver cancer	0.00013	0.00167	CcSEcCtD
Zidovudine—Urethral disorder—Doxorubicin—liver cancer	0.00013	0.00167	CcSEcCtD
Zidovudine—Mediastinal disorder—Epirubicin—liver cancer	0.000129	0.00166	CcSEcCtD
Zidovudine—Chills—Epirubicin—liver cancer	0.000129	0.00165	CcSEcCtD
Zidovudine—UGT2B7—liver—liver cancer	0.000127	0.0447	CbGeAlD
Zidovudine—Mental disorder—Epirubicin—liver cancer	0.000126	0.00161	CcSEcCtD
Zidovudine—Erythema multiforme—Doxorubicin—liver cancer	0.000125	0.00161	CcSEcCtD
Zidovudine—Malnutrition—Epirubicin—liver cancer	0.000125	0.0016	CcSEcCtD
Zidovudine—Erythema—Epirubicin—liver cancer	0.000125	0.0016	CcSEcCtD
Zidovudine—SLC22A11—liver—liver cancer	0.000124	0.0436	CbGeAlD
Zidovudine—Cardiac disorder—Doxorubicin—liver cancer	0.000123	0.00158	CcSEcCtD
Zidovudine—Flatulence—Epirubicin—liver cancer	0.000123	0.00158	CcSEcCtD
Zidovudine—Tension—Epirubicin—liver cancer	0.000122	0.00157	CcSEcCtD
Zidovudine—Dysgeusia—Epirubicin—liver cancer	0.000122	0.00157	CcSEcCtD
Zidovudine—SLC22A7—liver—liver cancer	0.000121	0.0425	CbGeAlD
Zidovudine—Nervousness—Epirubicin—liver cancer	0.000121	0.00156	CcSEcCtD
Zidovudine—Back pain—Epirubicin—liver cancer	0.000121	0.00155	CcSEcCtD
Zidovudine—Muscle spasms—Epirubicin—liver cancer	0.00012	0.00154	CcSEcCtD
Zidovudine—Mediastinal disorder—Doxorubicin—liver cancer	0.000119	0.00153	CcSEcCtD
Zidovudine—Chills—Doxorubicin—liver cancer	0.000119	0.00153	CcSEcCtD
Zidovudine—Mental disorder—Doxorubicin—liver cancer	0.000116	0.00149	CcSEcCtD
Zidovudine—Ill-defined disorder—Epirubicin—liver cancer	0.000116	0.00149	CcSEcCtD
Zidovudine—Malnutrition—Doxorubicin—liver cancer	0.000115	0.00148	CcSEcCtD
Zidovudine—Erythema—Doxorubicin—liver cancer	0.000115	0.00148	CcSEcCtD
Zidovudine—Anaemia—Epirubicin—liver cancer	0.000115	0.00148	CcSEcCtD
Zidovudine—Flatulence—Doxorubicin—liver cancer	0.000114	0.00146	CcSEcCtD
Zidovudine—Tension—Doxorubicin—liver cancer	0.000113	0.00145	CcSEcCtD
Zidovudine—Dysgeusia—Doxorubicin—liver cancer	0.000113	0.00145	CcSEcCtD
Zidovudine—Malaise—Epirubicin—liver cancer	0.000112	0.00144	CcSEcCtD
Zidovudine—Nervousness—Doxorubicin—liver cancer	0.000112	0.00144	CcSEcCtD
Zidovudine—Vertigo—Epirubicin—liver cancer	0.000112	0.00144	CcSEcCtD
Zidovudine—Syncope—Epirubicin—liver cancer	0.000112	0.00144	CcSEcCtD
Zidovudine—Leukopenia—Epirubicin—liver cancer	0.000112	0.00143	CcSEcCtD
Zidovudine—Back pain—Doxorubicin—liver cancer	0.000112	0.00143	CcSEcCtD
Zidovudine—Muscle spasms—Doxorubicin—liver cancer	0.000111	0.00143	CcSEcCtD
Zidovudine—Loss of consciousness—Epirubicin—liver cancer	0.00011	0.00141	CcSEcCtD
Zidovudine—Cough—Epirubicin—liver cancer	0.000109	0.0014	CcSEcCtD
Zidovudine—Convulsion—Epirubicin—liver cancer	0.000108	0.00139	CcSEcCtD
Zidovudine—Ill-defined disorder—Doxorubicin—liver cancer	0.000107	0.00138	CcSEcCtD
Zidovudine—Anaemia—Doxorubicin—liver cancer	0.000107	0.00137	CcSEcCtD
Zidovudine—Arthralgia—Epirubicin—liver cancer	0.000106	0.00136	CcSEcCtD
Zidovudine—Chest pain—Epirubicin—liver cancer	0.000106	0.00136	CcSEcCtD
Zidovudine—Myalgia—Epirubicin—liver cancer	0.000106	0.00136	CcSEcCtD
Zidovudine—Anxiety—Epirubicin—liver cancer	0.000106	0.00136	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000105	0.00135	CcSEcCtD
Zidovudine—Discomfort—Epirubicin—liver cancer	0.000105	0.00135	CcSEcCtD
Zidovudine—Malaise—Doxorubicin—liver cancer	0.000104	0.00134	CcSEcCtD
Zidovudine—Vertigo—Doxorubicin—liver cancer	0.000104	0.00133	CcSEcCtD
Zidovudine—Syncope—Doxorubicin—liver cancer	0.000103	0.00133	CcSEcCtD
Zidovudine—Leukopenia—Doxorubicin—liver cancer	0.000103	0.00133	CcSEcCtD
Zidovudine—Confusional state—Epirubicin—liver cancer	0.000103	0.00132	CcSEcCtD
Zidovudine—ABCC5—liver—liver cancer	0.000102	0.0357	CbGeAlD
Zidovudine—Oedema—Epirubicin—liver cancer	0.000102	0.00131	CcSEcCtD
Zidovudine—Anaphylactic shock—Epirubicin—liver cancer	0.000102	0.00131	CcSEcCtD
Zidovudine—Loss of consciousness—Doxorubicin—liver cancer	0.000101	0.0013	CcSEcCtD
Zidovudine—Cough—Doxorubicin—liver cancer	0.000101	0.00129	CcSEcCtD
Zidovudine—Shock—Epirubicin—liver cancer	0.0001	0.00129	CcSEcCtD
Zidovudine—Convulsion—Doxorubicin—liver cancer	0.0001	0.00128	CcSEcCtD
Zidovudine—Nervous system disorder—Epirubicin—liver cancer	9.98e-05	0.00128	CcSEcCtD
Zidovudine—Thrombocytopenia—Epirubicin—liver cancer	9.97e-05	0.00128	CcSEcCtD
Zidovudine—Skin disorder—Epirubicin—liver cancer	9.89e-05	0.00127	CcSEcCtD
Zidovudine—Hyperhidrosis—Epirubicin—liver cancer	9.84e-05	0.00126	CcSEcCtD
Zidovudine—Myalgia—Doxorubicin—liver cancer	9.82e-05	0.00126	CcSEcCtD
Zidovudine—Chest pain—Doxorubicin—liver cancer	9.82e-05	0.00126	CcSEcCtD
Zidovudine—Arthralgia—Doxorubicin—liver cancer	9.82e-05	0.00126	CcSEcCtD
Zidovudine—Anxiety—Doxorubicin—liver cancer	9.79e-05	0.00126	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	9.76e-05	0.00125	CcSEcCtD
Zidovudine—Discomfort—Doxorubicin—liver cancer	9.71e-05	0.00125	CcSEcCtD
Zidovudine—Anorexia—Epirubicin—liver cancer	9.7e-05	0.00125	CcSEcCtD
Zidovudine—Confusional state—Doxorubicin—liver cancer	9.5e-05	0.00122	CcSEcCtD
Zidovudine—Anaphylactic shock—Doxorubicin—liver cancer	9.42e-05	0.00121	CcSEcCtD
Zidovudine—Oedema—Doxorubicin—liver cancer	9.42e-05	0.00121	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Epirubicin—liver cancer	9.27e-05	0.00119	CcSEcCtD
Zidovudine—Shock—Doxorubicin—liver cancer	9.27e-05	0.00119	CcSEcCtD
Zidovudine—Nervous system disorder—Doxorubicin—liver cancer	9.24e-05	0.00119	CcSEcCtD
Zidovudine—Thrombocytopenia—Doxorubicin—liver cancer	9.22e-05	0.00118	CcSEcCtD
Zidovudine—Insomnia—Epirubicin—liver cancer	9.21e-05	0.00118	CcSEcCtD
Zidovudine—Skin disorder—Doxorubicin—liver cancer	9.15e-05	0.00118	CcSEcCtD
Zidovudine—Paraesthesia—Epirubicin—liver cancer	9.14e-05	0.00117	CcSEcCtD
Zidovudine—CYP2A6—liver—liver cancer	9.13e-05	0.032	CbGeAlD
Zidovudine—Hyperhidrosis—Doxorubicin—liver cancer	9.11e-05	0.00117	CcSEcCtD
Zidovudine—Dyspnoea—Epirubicin—liver cancer	9.08e-05	0.00117	CcSEcCtD
Zidovudine—Somnolence—Epirubicin—liver cancer	9.05e-05	0.00116	CcSEcCtD
Zidovudine—Anorexia—Doxorubicin—liver cancer	8.98e-05	0.00115	CcSEcCtD
Zidovudine—Dyspepsia—Epirubicin—liver cancer	8.96e-05	0.00115	CcSEcCtD
Zidovudine—Decreased appetite—Epirubicin—liver cancer	8.85e-05	0.00114	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Epirubicin—liver cancer	8.79e-05	0.00113	CcSEcCtD
Zidovudine—Fatigue—Epirubicin—liver cancer	8.78e-05	0.00113	CcSEcCtD
Zidovudine—Constipation—Epirubicin—liver cancer	8.7e-05	0.00112	CcSEcCtD
Zidovudine—Pain—Epirubicin—liver cancer	8.7e-05	0.00112	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Doxorubicin—liver cancer	8.58e-05	0.0011	CcSEcCtD
Zidovudine—Insomnia—Doxorubicin—liver cancer	8.52e-05	0.00109	CcSEcCtD
Zidovudine—Paraesthesia—Doxorubicin—liver cancer	8.46e-05	0.00109	CcSEcCtD
Zidovudine—Dyspnoea—Doxorubicin—liver cancer	8.4e-05	0.00108	CcSEcCtD
Zidovudine—Feeling abnormal—Epirubicin—liver cancer	8.39e-05	0.00108	CcSEcCtD
Zidovudine—Somnolence—Doxorubicin—liver cancer	8.37e-05	0.00108	CcSEcCtD
Zidovudine—Gastrointestinal pain—Epirubicin—liver cancer	8.32e-05	0.00107	CcSEcCtD
Zidovudine—Dyspepsia—Doxorubicin—liver cancer	8.29e-05	0.00106	CcSEcCtD
Zidovudine—Decreased appetite—Doxorubicin—liver cancer	8.19e-05	0.00105	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Doxorubicin—liver cancer	8.13e-05	0.00104	CcSEcCtD
Zidovudine—Fatigue—Doxorubicin—liver cancer	8.12e-05	0.00104	CcSEcCtD
Zidovudine—Urticaria—Epirubicin—liver cancer	8.09e-05	0.00104	CcSEcCtD
Zidovudine—Constipation—Doxorubicin—liver cancer	8.05e-05	0.00103	CcSEcCtD
Zidovudine—Pain—Doxorubicin—liver cancer	8.05e-05	0.00103	CcSEcCtD
Zidovudine—Abdominal pain—Epirubicin—liver cancer	8.05e-05	0.00103	CcSEcCtD
Zidovudine—Body temperature increased—Epirubicin—liver cancer	8.05e-05	0.00103	CcSEcCtD
Zidovudine—Feeling abnormal—Doxorubicin—liver cancer	7.76e-05	0.000997	CcSEcCtD
Zidovudine—Gastrointestinal pain—Doxorubicin—liver cancer	7.7e-05	0.000989	CcSEcCtD
Zidovudine—Urticaria—Doxorubicin—liver cancer	7.48e-05	0.000961	CcSEcCtD
Zidovudine—Body temperature increased—Doxorubicin—liver cancer	7.45e-05	0.000956	CcSEcCtD
Zidovudine—Abdominal pain—Doxorubicin—liver cancer	7.45e-05	0.000956	CcSEcCtD
Zidovudine—Asthenia—Epirubicin—liver cancer	7.3e-05	0.000938	CcSEcCtD
Zidovudine—ALB—liver—liver cancer	7.29e-05	0.0256	CbGeAlD
Zidovudine—Pruritus—Epirubicin—liver cancer	7.2e-05	0.000925	CcSEcCtD
Zidovudine—ABCC4—liver—liver cancer	7.06e-05	0.0248	CbGeAlD
Zidovudine—Diarrhoea—Epirubicin—liver cancer	6.96e-05	0.000895	CcSEcCtD
Zidovudine—Asthenia—Doxorubicin—liver cancer	6.76e-05	0.000868	CcSEcCtD
Zidovudine—Dizziness—Epirubicin—liver cancer	6.73e-05	0.000865	CcSEcCtD
Zidovudine—Pruritus—Doxorubicin—liver cancer	6.66e-05	0.000856	CcSEcCtD
Zidovudine—Vomiting—Epirubicin—liver cancer	6.47e-05	0.000831	CcSEcCtD
Zidovudine—Diarrhoea—Doxorubicin—liver cancer	6.44e-05	0.000828	CcSEcCtD
Zidovudine—Rash—Epirubicin—liver cancer	6.42e-05	0.000824	CcSEcCtD
Zidovudine—Dermatitis—Epirubicin—liver cancer	6.41e-05	0.000824	CcSEcCtD
Zidovudine—Headache—Epirubicin—liver cancer	6.38e-05	0.000819	CcSEcCtD
Zidovudine—Dizziness—Doxorubicin—liver cancer	6.23e-05	0.0008	CcSEcCtD
Zidovudine—Nausea—Epirubicin—liver cancer	6.05e-05	0.000777	CcSEcCtD
Zidovudine—Vomiting—Doxorubicin—liver cancer	5.99e-05	0.000769	CcSEcCtD
Zidovudine—Rash—Doxorubicin—liver cancer	5.94e-05	0.000763	CcSEcCtD
Zidovudine—Dermatitis—Doxorubicin—liver cancer	5.93e-05	0.000762	CcSEcCtD
Zidovudine—Headache—Doxorubicin—liver cancer	5.9e-05	0.000758	CcSEcCtD
Zidovudine—CYP2C19—liver—liver cancer	5.87e-05	0.0206	CbGeAlD
Zidovudine—Nausea—Doxorubicin—liver cancer	5.59e-05	0.000719	CcSEcCtD
Zidovudine—ABCB1—embryo—liver cancer	5.31e-05	0.0186	CbGeAlD
Zidovudine—CYP2C8—liver—liver cancer	5.13e-05	0.018	CbGeAlD
Zidovudine—ABCG2—liver—liver cancer	4.98e-05	0.0175	CbGeAlD
Zidovudine—CYP2C9—liver—liver cancer	4.55e-05	0.016	CbGeAlD
Zidovudine—CYP3A4—liver—liver cancer	3.47e-05	0.0122	CbGeAlD
Zidovudine—ABCB1—liver—liver cancer	2.46e-05	0.00862	CbGeAlD
Zidovudine—ABCG2—Metabolism—GSTP1—liver cancer	6.93e-06	7.71e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—HRAS—liver cancer	6.88e-06	7.65e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	6.87e-06	7.64e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GSTP1—liver cancer	6.86e-06	7.63e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CG—liver cancer	6.86e-06	7.63e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ALDOB—liver cancer	6.85e-06	7.62e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	6.85e-06	7.62e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—HMOX1—liver cancer	6.84e-06	7.61e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTA2—liver cancer	6.83e-06	7.6e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—HMOX1—liver cancer	6.77e-06	7.53e-05	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—AKT1—liver cancer	6.74e-06	7.51e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ALDOB—liver cancer	6.69e-06	7.44e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PPARG—liver cancer	6.62e-06	7.37e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	6.59e-06	7.33e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTA1—liver cancer	6.59e-06	7.33e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—STAT3—liver cancer	6.58e-06	7.32e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	6.55e-06	7.29e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CRABP1—liver cancer	6.53e-06	7.27e-05	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	6.52e-06	7.26e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—NAT2—liver cancer	6.51e-06	7.25e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	6.42e-06	7.15e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—HPGDS—liver cancer	6.4e-06	7.12e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CRABP1—liver cancer	6.38e-06	7.1e-05	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	6.38e-06	7.09e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GSTM1—liver cancer	6.37e-06	7.09e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—HPGDS—liver cancer	6.36e-06	7.08e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.36e-06	7.08e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PIK3CD—liver cancer	6.33e-06	7.04e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.33e-06	7.04e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GSTM1—liver cancer	6.3e-06	7.01e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GSTP1—liver cancer	6.3e-06	7.01e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	6.26e-06	6.97e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—SERPINE1—liver cancer	6.26e-06	6.96e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ALDOB—liver cancer	6.25e-06	6.95e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	6.21e-06	6.91e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—HMOX1—liver cancer	6.21e-06	6.91e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MYC—liver cancer	6.11e-06	6.8e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—TGFB1—liver cancer	6.1e-06	6.79e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—AKT1—liver cancer	6.07e-06	6.75e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CYP1A1—liver cancer	6.04e-06	6.72e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CD—liver cancer	6.03e-06	6.71e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CYP1A1—liver cancer	5.98e-06	6.65e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CRABP1—liver cancer	5.96e-06	6.63e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—ALB—liver cancer	5.95e-06	6.62e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.88e-06	6.55e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.79e-06	6.45e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GSTM1—liver cancer	5.79e-06	6.44e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.76e-06	6.41e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.72e-06	6.36e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—HPGDS—liver cancer	5.71e-06	6.36e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PSMA4—liver cancer	5.7e-06	6.35e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PSMD10—liver cancer	5.7e-06	6.35e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.68e-06	6.32e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PSMA4—liver cancer	5.67e-06	6.31e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PSMD10—liver cancer	5.67e-06	6.31e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—RAF1—liver cancer	5.65e-06	6.29e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—KRAS—liver cancer	5.65e-06	6.29e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—MTHFR—liver cancer	5.63e-06	6.26e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—HPGDS—liver cancer	5.57e-06	6.2e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—MTHFR—liver cancer	5.57e-06	6.2e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GOT2—liver cancer	5.55e-06	6.17e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PPARA—liver cancer	5.52e-06	6.15e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GOT2—liver cancer	5.52e-06	6.14e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PIK3CB—liver cancer	5.52e-06	6.14e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CYP1A1—liver cancer	5.49e-06	6.1e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PPARA—liver cancer	5.47e-06	6.08e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.36e-06	5.97e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GLUL—liver cancer	5.33e-06	5.93e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CPT1B—liver cancer	5.33e-06	5.93e-05	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	5.33e-06	5.93e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CB—liver cancer	5.26e-06	5.85e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	5.25e-06	5.84e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP2E1—liver cancer	5.22e-06	5.8e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—HPGDS—liver cancer	5.21e-06	5.79e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PIK3CA—liver cancer	5.19e-06	5.78e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP2E1—liver cancer	5.19e-06	5.77e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.18e-06	5.76e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.17e-06	5.75e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NR1H4—liver cancer	5.14e-06	5.72e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—MTHFR—liver cancer	5.11e-06	5.69e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.11e-06	5.68e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PSMA4—liver cancer	5.09e-06	5.66e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PSMD10—liver cancer	5.09e-06	5.66e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—IL2—liver cancer	5.07e-06	5.64e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTA3—liver cancer	5.05e-06	5.62e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.05e-06	5.62e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.02e-06	5.59e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PPARA—liver cancer	5.02e-06	5.58e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PSMA4—liver cancer	4.97e-06	5.53e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PSMD10—liver cancer	4.97e-06	5.53e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GOT2—liver cancer	4.95e-06	5.51e-05	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	4.89e-06	5.44e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYCS—liver cancer	4.88e-06	5.43e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYCS—liver cancer	4.85e-06	5.4e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GOT2—liver cancer	4.83e-06	5.38e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—HRAS—liver cancer	4.8e-06	5.34e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GOT1—liver cancer	4.79e-06	5.33e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GGT1—liver cancer	4.79e-06	5.33e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GGT1—liver cancer	4.76e-06	5.3e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GOT1—liver cancer	4.76e-06	5.3e-05	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	4.74e-06	5.27e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CG—liver cancer	4.73e-06	5.26e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.72e-06	5.25e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CG—liver cancer	4.68e-06	5.21e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP2E1—liver cancer	4.66e-06	5.18e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.66e-06	5.18e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PSMA4—liver cancer	4.64e-06	5.16e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PSMD10—liver cancer	4.64e-06	5.16e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTA4—liver cancer	4.62e-06	5.14e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—IL6—liver cancer	4.6e-06	5.11e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PPARG—liver cancer	4.57e-06	5.08e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP2E1—liver cancer	4.54e-06	5.06e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PPARG—liver cancer	4.52e-06	5.03e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GOT2—liver cancer	4.52e-06	5.02e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.51e-06	5.02e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTA2—liver cancer	4.5e-06	5.01e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYCS—liver cancer	4.36e-06	4.85e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PIK3CA—liver cancer	4.35e-06	4.84e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTA1—liver cancer	4.34e-06	4.83e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—VEGFA—liver cancer	4.31e-06	4.79e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTP1—liver cancer	4.3e-06	4.79e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CG—liver cancer	4.3e-06	4.78e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NAT2—liver cancer	4.3e-06	4.78e-05	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	4.29e-06	4.77e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTP1—liver cancer	4.28e-06	4.76e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GOT1—liver cancer	4.27e-06	4.76e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GGT1—liver cancer	4.27e-06	4.76e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYCS—liver cancer	4.25e-06	4.73e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP2E1—liver cancer	4.25e-06	4.72e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—HMOX1—liver cancer	4.24e-06	4.72e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—AKT1—liver cancer	4.24e-06	4.72e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—HMOX1—liver cancer	4.22e-06	4.69e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GGT1—liver cancer	4.17e-06	4.64e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GOT1—liver cancer	4.17e-06	4.64e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CD—liver cancer	4.16e-06	4.63e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PPARG—liver cancer	4.15e-06	4.62e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ALDOB—liver cancer	4.12e-06	4.58e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CD—liver cancer	4.12e-06	4.58e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.11e-06	4.57e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—ALB—liver cancer	4.1e-06	4.57e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—ALB—liver cancer	4.06e-06	4.52e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYCS—liver cancer	3.97e-06	4.42e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTM1—liver cancer	3.95e-06	4.4e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TGFB1—liver cancer	3.95e-06	4.4e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTM1—liver cancer	3.93e-06	4.37e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CRABP1—liver cancer	3.93e-06	4.37e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GGT1—liver cancer	3.9e-06	4.34e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GOT1—liver cancer	3.9e-06	4.34e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTP1—liver cancer	3.84e-06	4.27e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—HMOX1—liver cancer	3.79e-06	4.21e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CD—liver cancer	3.78e-06	4.2e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTP1—liver cancer	3.75e-06	4.17e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP1A1—liver cancer	3.75e-06	4.17e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ALB—liver cancer	3.73e-06	4.15e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP1A1—liver cancer	3.73e-06	4.15e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—HMOX1—liver cancer	3.7e-06	4.11e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—KRAS—liver cancer	3.66e-06	4.07e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CB—liver cancer	3.62e-06	4.03e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CB—liver cancer	3.59e-06	3.99e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—AKT1—liver cancer	3.55e-06	3.95e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTM1—liver cancer	3.53e-06	3.93e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTP1—liver cancer	3.5e-06	3.9e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—MTHFR—liver cancer	3.49e-06	3.89e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—MTHFR—liver cancer	3.47e-06	3.87e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—HMOX1—liver cancer	3.45e-06	3.84e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTM1—liver cancer	3.44e-06	3.83e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—HPGDS—liver cancer	3.43e-06	3.82e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PPARA—liver cancer	3.43e-06	3.81e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PPARA—liver cancer	3.41e-06	3.79e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PIK3CA—liver cancer	3.36e-06	3.74e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP1A1—liver cancer	3.35e-06	3.72e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CB—liver cancer	3.29e-06	3.66e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP1A1—liver cancer	3.26e-06	3.63e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—liver cancer	3.25e-06	3.62e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTM1—liver cancer	3.22e-06	3.58e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CA—liver cancer	3.2e-06	3.57e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—MTHFR—liver cancer	3.12e-06	3.47e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—HRAS—liver cancer	3.11e-06	3.46e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.08e-06	3.43e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.06e-06	3.41e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PSMD10—liver cancer	3.06e-06	3.41e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PSMA4—liver cancer	3.06e-06	3.41e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PPARA—liver cancer	3.06e-06	3.4e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP1A1—liver cancer	3.05e-06	3.39e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—MTHFR—liver cancer	3.04e-06	3.39e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PPARA—liver cancer	2.99e-06	3.32e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GOT2—liver cancer	2.98e-06	3.31e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CG—liver cancer	2.94e-06	3.27e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CG—liver cancer	2.92e-06	3.25e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—MTHFR—liver cancer	2.84e-06	3.16e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PPARG—liver cancer	2.83e-06	3.15e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PPARG—liver cancer	2.82e-06	3.13e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP2E1—liver cancer	2.8e-06	3.12e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PPARA—liver cancer	2.79e-06	3.1e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.75e-06	3.06e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—AKT1—liver cancer	2.75e-06	3.06e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CG—liver cancer	2.62e-06	2.92e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYCS—liver cancer	2.62e-06	2.91e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—AKT1—liver cancer	2.62e-06	2.91e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CD—liver cancer	2.58e-06	2.87e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GGT1—liver cancer	2.57e-06	2.86e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GOT1—liver cancer	2.57e-06	2.86e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CD—liver cancer	2.57e-06	2.86e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CG—liver cancer	2.56e-06	2.85e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ALB—liver cancer	2.55e-06	2.83e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PPARG—liver cancer	2.53e-06	2.81e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.51e-06	2.79e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PPARG—liver cancer	2.47e-06	2.75e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CG—liver cancer	2.39e-06	2.66e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTP1—liver cancer	2.31e-06	2.57e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PPARG—liver cancer	2.31e-06	2.57e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CD—liver cancer	2.3e-06	2.56e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—HMOX1—liver cancer	2.28e-06	2.53e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ALB—liver cancer	2.27e-06	2.53e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CB—liver cancer	2.25e-06	2.5e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CD—liver cancer	2.25e-06	2.5e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CB—liver cancer	2.24e-06	2.49e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ALB—liver cancer	2.22e-06	2.47e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CA—liver cancer	2.21e-06	2.46e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CA—liver cancer	2.19e-06	2.43e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTM1—liver cancer	2.12e-06	2.36e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CD—liver cancer	2.1e-06	2.34e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ALB—liver cancer	2.07e-06	2.31e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP1A1—liver cancer	2.01e-06	2.24e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CB—liver cancer	2.01e-06	2.23e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CA—liver cancer	2.01e-06	2.23e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CB—liver cancer	1.96e-06	2.18e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—MTHFR—liver cancer	1.88e-06	2.09e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PPARA—liver cancer	1.84e-06	2.05e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CB—liver cancer	1.83e-06	2.04e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—AKT1—liver cancer	1.8e-06	2.01e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—AKT1—liver cancer	1.79e-06	1.99e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—AKT1—liver cancer	1.64e-06	1.82e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CG—liver cancer	1.58e-06	1.75e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PPARG—liver cancer	1.52e-06	1.69e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CD—liver cancer	1.39e-06	1.54e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CA—liver cancer	1.37e-06	1.53e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ALB—liver cancer	1.37e-06	1.52e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CA—liver cancer	1.36e-06	1.52e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CA—liver cancer	1.22e-06	1.36e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CB—liver cancer	1.21e-06	1.34e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CA—liver cancer	1.19e-06	1.33e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—AKT1—liver cancer	1.12e-06	1.25e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CA—liver cancer	1.12e-06	1.24e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—AKT1—liver cancer	1.11e-06	1.24e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—AKT1—liver cancer	1e-06	1.11e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—AKT1—liver cancer	9.76e-07	1.09e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—AKT1—liver cancer	9.12e-07	1.01e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CA—liver cancer	7.36e-07	8.19e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—AKT1—liver cancer	6.01e-07	6.69e-06	CbGpPWpGaD
